TXP Medical Publishes Whitepaper "The State of Japanese Real-World Evidence," Analyzing the Current State of Real-World Evidence (RWE) in Japan

Markets PR Newswire By PR Newswire 04 Nov 2026 01:30 1 min read
TXP Medical Publishes Whitepaper "The State of Japanese Real-World Evidence," Analyzing the Current State of Real-World Evidence (RWE) in Japan

~ EMR-derived data market to grow from approx. ¥3.9 billion (2025) to approx. ¥25 billion (2035) ~ ~ RWD/RWE use in new approvals up from 18.1% (2019) to 30.4% (2024) ~ ~ Claims/DPC and EMR data: complementary roles clarified for Medical Affairs ~ TOKYO, Nov. 3, 2026 /PRNewswire/ -- TXP...

Covered in this story

Analyst targets on Emerson Electric

Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.

Call it yourself

No member calls on $EMR yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Emerson Electric →
Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.